This webinar is moderated by PanCAN's President & CEO, Julie Fleshman. Pancreatic cancer experts answer frequently asked questions that have come from our pancreatic cancer community. This third session covers topics such as access to treatments and patient safety as states move into the next phase of reopening.
This webinar was recorded on June 11, 2020. The presenters are Julie Fleshman, MBA, JD – PanCAN, Andrew M. Lowy, MD, FACS – UC San Diego Health Moores Cancer Center, Margaret A. Tempero, MD – UC San Francisco Pancreas Center
Thank you to our webinar sponsors: AstraZeneca and Ipsen
Thank you to our Scientific & Medical Affairs Industry Members: AbbVie, AngioDynamics, AstraZeneca, Ipsen, Janssen Oncology, Pfizer, Rafael Pharmaceuticals, Tempus, TriSalus and TYME.
################
Do you know someone diagnosed with pancreatic cancer? Direct them to Patient Central for information, resources and hope. Call 877-2-PANCAN, email patientservices@pancan.org or visit [ Ссылка ]. Associates are available Monday – Friday, 7 a.m. – 5 p.m. PT.
################
CONNECT WITH US
WEBSITE: [ Ссылка ]
FACEBOOK: [ Ссылка ]
TWITTER: [ Ссылка ]
INSTAGRAM: [ Ссылка ]
YOUTUBE: [ Ссылка ]
and MORE: [ Ссылка ]
################
ABOUT PANCREATIC CANCER ACTION NETWORK
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival.
